<p>Innovative researcher and clinical practitioner in the field of regenerative-orthobiological medicine applications, with extensive teaching and educational program development experience. He started his career in regenerative technologies in 1989 in the Netherlands. Created the first in-hospital autologous biological department to serve patients in cardiac, orthopedic, reconstructive surgical, and vascular-wound care procedures. In 2011, he initiated the concept of advanced biological wound care combined with hyperbaric medicine, using platelet-rich plasma and mesenchymal stem cell therapies in patients with diverse chronic non-healing wounds. Analytical strategist skilled in successfully navigating evidence based clinical protocols and application technologies through the concept, development, and implementation phases of new regenerative healthcare medicine initiatives. His focus is on building relationships and promoting cellular therapy programs across educational, and global healthcare organizations to drive positive transformation of regenerative medicine concepts, cohesive clinical approaches, and enhance patient outcomes. He is a comfortable and experienced teacher for physicians and health care providers in autologous biologics. In 2017 he moved to the US to for the next phase in his career, as he is acting Chief Scientific Officer of EmCyte Corp., and Program director of Gulf Coast Biologics Research &#038; Educational Center. Recently he is appointed as International Professor at the Frontiers Health Program of the Faculty of Medicine of the Max Planck University Center, in Indaiatuba – São Paulo Brasil. Here, his responsibilities include teaching of post graduate courses and management of clinical projects in non-interventional regenerative medicine therapies. He is international advisor to a clinical research program and study in patients with spinal cord trauma, using, among others, patients own biological tissues. Professor Everts is an internationally recognized educator, scientist, and contributor in many regenerative medicine applications, featuring blood-derived products. He has published over 75 peer reviewed articles and book chapters, including the first textbook on Platelet-Rich Plasma.</p>


Peter A. Everts, PhD, FRSM